Institutional Portfolio Rebalancing
Institutional Investors Actively Adjust Holdings in Flowserve and Palantir During Second Quarter
Key Points
Flowserve's precise 12-month price range is $48.71 to $92.41, a detail not fully captured in the summary and illustrating the stock's volatility over the past year.
In Q2, Flowserve attracted several new institutional positions at small sizes, including BOKF NA (~$28k), Mitsubishi UFJ Asset Management (~$34k), Atlas Capital Advisors (~$36k), Measured Wealth Private Client Group (~$36k), and Global Retirement Partners (~$38k).
Arrowstreet Capital's Palantir stake jumped 277.4% in Q1 to 10,446,959 shares, representing a substantial uplift in its PLTR position (roughly $1.53 billion).
State Street Corp significantly expanded Palantir exposure to 101,258,899 shares, estimated at about $18.47 billion, underscoring robust institutional demand for PLTR.
Norges Bank opened a new Palantir position in the fourth quarter, worth approximately $5.15 billion, highlighting continued sovereign-level interest in Palantir.
Hedge funds are actively reshuffling their positions in both Flowserve Corporation and Palantir Technologies heading into the second half of 2025. Pallas Capital Advisors LLC made a fresh $1.44 million bet on Flowserve in Q2, picking up 19,478 shares, while Van Cleef Asset Management trimmed its Palantir stake by 2.5% to 408,853 shares, according to Ticker Report.
The moves reflect a broader wave of institutional repositioning around two very different stocks — one an industrial pump maker, the other an AI data giant. Institutions now own about 93.9% of Flowserve, while hedge funds collectively hold roughly 45.65% of Palantir.
Small Funds Pour Into Flowserve as Institutions Dominate
Flowserve has become a crowded institutional trade. Beyond Pallas Capital's $1.44 million buy, several smaller funds opened new positions in Q2, according to Watchlist News. BOKF NA put in about $28,000. Mitsubishi UFJ Asset Management added roughly $34,000. Atlas Capital Advisors, Measured Wealth Private Client Group, and Global Retirement Partners each added between $36,000 and $38,000.
Flowserve's stock has had a volatile year. Its 12-month price range runs from $48.71 to $92.41 — nearly double from trough to peak. The 50-day moving average sits near $75. Analysts have mixed views: Weiss Ratings recently upgraded the stock, while TD Cowen adjusted its price target in the latest quarter, according to Ticker Report.
Palantir Draws Sovereign and Mega-Fund Buyers at Scale
While some funds trimmed Palantir, the biggest players were buying heavily. Norges Bank, Norway's sovereign wealth fund, opened a brand-new position worth approximately $5.15 billion. State Street Corp expanded its stake to 101,258,899 shares — valued at roughly $18.47 billion. Jennison Associates also opened a new position during the quarter, according to Ticker Report.
Arrowstreet Capital made one of the boldest moves. The fund grew its Palantir stake by 277.4% in Q1, reaching 10,446,959 shares worth about $1.53 billion. That kind of aggressive buying signals strong conviction in Palantir's growth story among large quantitative and institutional managers.
Smaller Managers Cut Palantir Amid Ongoing Repositioning
Not everyone was adding to Palantir. Van Cleef Asset Management cut its stake by 2.5%, leaving PLTR at about 4.9% of its total portfolio. Steadview Capital Management, Hedeker Wealth, and Gateway Wealth Partners also trimmed positions during the quarter, according to Ticker Report. The reductions suggest some managers are locking in gains after a strong run.
Still, the net picture for Palantir is bullish. Hedge funds collectively own about 45.65% of the company's shares. Analysts continue to cite strong earnings momentum as a key driver. Palantir's AI platform business has drawn repeated positive commentary, keeping price targets elevated across Wall Street.
Pallas Capital Spreads Industrial Bets Beyond Flowserve
Pallas Capital Advisors was busy across the industrial sector in Q2. Beyond the Flowserve buy, the fund took a $3.25 million stake in TechnipFMC, an oil and gas equipment company, picking up 49,009 shares, according to Ticker Report. It also opened a new position in Parker-Hannifin, the industrial products giant, buying 9,239 shares.
The fund also initiated a fresh $1.56 million position in Neurocrine Biosciences, buying 9,265 shares in Q2, according to Watchlist News. The flurry of new buys suggests Pallas is broadening its portfolio across industrials and healthcare, rather than concentrating on any single bet.
Sentiment
Mostly PositivePublishers
30
Articles
49
Reach
79
